- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01113788
Tricuspid Isthmus Imaged by CARTOsound, Patients With Typical Atrial Flutter
Tricuspid Isthmus Architecture as Imaged by CARTOsound, Determines Ablation Times in Patients With Typical Atrial Flutter
The investigators propose a third hypothesis based on the anatomic observations made in pathological studies. The investigators hypothesize that the anatomic architecture determines the functional properties of the TV-IVC isthmus. As a result,
• Muscular bundles are preferential routes of conduction through the TV-IVC isthmus. The isthmus acts like a series of discreet conduction routes rather than as a sheet of tissue.
The muscular bundles form selective targets for ablation and therefore the entire anatomic line need not be ablated. This has direct implications for ablation of the isthmus.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Allan Skanes, MD
- Phone Number: 519-663-3746
- Email: askanes@uwo.ca
Study Contact Backup
- Name: Cathy Bentley
- Phone Number: 519-685-8500-32835
- Email: cbentl@uwo.ca
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 5A5
- Recruiting
- London Health Sciences Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients must be over 18 years of age provided written informed consent documented atrial flutter by ECG , holter monitor or TTM
Exclusion Criteria:
- previous atrial flutter ablation non isthmus dependent atrial flutter prior right atrial surgery
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
imaging
imaging with usual catheter/fluoroscopy, no cartosound
|
tricuspid isthmus imaging with Cartosound
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
observational including ablation lesion number, ablation time in minutes, fluoroscopic
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Allan Skanes, MD, FRCPC, London Health Sciences Centre
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R-09-414
- 16214 (Other Identifier: REB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Flutter
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
University of PennsylvaniaWithdrawnTypical Atrial Flutter | Risk Factors With Future Development of Atrial FlutterUnited States
-
Angelo BivianoCompleted
-
Kaiser PermanenteActive, not recruitingAtrial Fibrillation and FlutterUnited States
-
Charles University, Czech RepublicCompleted
-
Hospital Universitario Central de AsturiasJohnson & JohnsonUnknown
-
Hangzhou Dinova EP Technology Co., LtdNot yet recruiting
-
University of ManchesterManchester University NHS Foundation TrustWithdrawn
-
Abbott Medical DevicesCompletedTypical Atrial FlutterUnited States, Canada
-
Abbott Medical DevicesCompletedTypical Atrial FlutterUnited States, Canada
Clinical Trials on tricuspid isthmus imaging with Cartosound
-
Deutsches Herzzentrum MuenchenBoston Scientific CorporationUnknown
-
Yonsei UniversityCompletedAtrial FibrillationKorea, Republic of
-
University of California, San DiegoCatheter Robotics, Inc.CompletedAtrial Fibrillation | Atrial FlutterUnited States
-
CorMatrix Cardiovascular, Inc.Yale UniversityRecruitingTricuspid Valve Insufficiency | Tricuspid Valve DiseaseUnited States
-
Michele De BonisCompletedFunctional Tricuspid RegurgitationItaly
-
University of RostockMedtronic; Biosense Webster, Inc.Unknown
-
Rennes University HospitalCompletedTricuspid Regurgitation | Remodeling, CardiacFrance
-
CMC Ambroise ParéCompletedHeart Diseases | Heart Failure | Postoperative Complications | Heart Valve DiseasesFrance
-
University of Wisconsin, MadisonTerminatedHead and Neck Cancer | Esophageal Cancer | Lung Cancer | Prostate Cancer | CNS Brain MetastasesUnited States
-
Beth Israel Deaconess Medical CenterCompleted